Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
Authors:
Top Cited Papers
- 4 December 2023
- Vol. 82 (24) , 2265-2276
Abstract
No abstract availableKeywords
Funding Information
- Hjerteforeningen
- Gangstedfonden
- Novo Nordisk Foundation
This publication has 42 references indexed in Scilit:
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)The American Journal of Cardiology, 2010
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Asymptomatic Peripheral Arterial Disease Is Associated With More Adverse Lower Extremity Characteristics Than Intermittent ClaudicationCirculation, 2008
- Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White PopulationsMayo Clinic Proceedings, 2007
- Risk Factors for Progression of Peripheral Arterial Disease in Large and Small VesselsCirculation, 2006
- Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*International Journal of Epidemiology, 2003
- Asymptomatic Peripheral Arterial Disease Is Independently Associated With Impaired Lower Extremity FunctioningCirculation, 2000
- Lipoprotein(a) in Stored Plasma Samples and the Ravages of TimeArteriosclerosis, Thrombosis, and Vascular Biology, 1996